Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ICG Imaging for Peritoneal Carcinomatosis in Colorectal Cancer
NCT02032485Phase 2Completed
- Sponsor
- Institut Jules Bordet
- Start
- Mar 2013
- Primary completion
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of indocyanine green in colorectal cancer (CRC) and peritoneal carcinomatosis (PC), sponsored by Institut Jules Bordet. Primary endpoint: Fluorescence intensity of tumoral and healthy tissues at 1 week. Started Mar 2013; status: completed.
02
Drugs
indocyanine green
03
Conditions
colorectal cancer (CRC)peritoneal carcinomatosis (PC)
Beyond the preview
Go deeper on NCT02032485.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02032485.